Kilitch Change To Netincome from 2010 to 2025
| KILITCH Stock | 362.60 20.85 6.10% |
Change To Netincome | First Reported 2010-12-31 | Previous Quarter 49.6 M | Current Value 52.1 M | Quarterly Volatility 48.8 M |
Check Kilitch Drugs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kilitch Drugs' main balance sheet or income statement drivers, such as Depreciation And Amortization of 32.6 M, Interest Expense of 72.9 M or Selling General Administrative of 25 M, as well as many indicators such as . Kilitch financial statements analysis is a perfect complement when working with Kilitch Drugs Valuation or Volatility modules.
Kilitch | Change To Netincome |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Other Information on Investing in Kilitch Stock
Kilitch Drugs financial ratios help investors to determine whether Kilitch Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kilitch with respect to the benefits of owning Kilitch Drugs security.